Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKB500 Combinations in Esophageal Squamous Cell Carcinoma
NCT07700667Phase 2Recruiting
- Sponsor
- Kelun-Biotech
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of SKB500 in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Kelun-Biotech. Started Aug 2026; status: recruiting.
02
Drugs
SKB500
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT07700667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07700667.